{
    "id": 3356,
    "fullName": "MET N375S",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "MET N375S lies within the extracellular Sema ligand-binding domain of the Met protein (UniProt.org). N375S is predicted to confer a loss of function to the Met protein, as demonstrated by decreased Met binding affinity for Hgf in cell culture (PMID: 19723643).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 2020,
                    "pubMedId": 19723643,
                    "title": "Ethnic differences and functional analysis of MET mutations in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19723643"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4233,
        "geneSymbol": "MET",
        "terms": [
            "MET",
            "AUTS9",
            "c-Met",
            "DFNB97",
            "HGFR",
            "RCCP2"
        ]
    },
    "variant": "N375S",
    "createDate": "02/25/2015",
    "updateDate": "09/17/2018",
    "referenceTranscriptCoordinates": {
        "id": 144817,
        "transcript": "NM_000245",
        "gDna": "chr7:g.116700208A>G",
        "cDna": "c.1124A>G",
        "protein": "p.N375S",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2622,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing MET N375S had decreased sensitivity to SU11274 in culture compared to cells expressing wild-type MET (PMID: 19723643).",
            "molecularProfile": {
                "id": 3165,
                "profileName": "MET N375S"
            },
            "therapy": {
                "id": 1089,
                "therapyName": "SU11274",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 2020,
                    "pubMedId": 19723643,
                    "title": "Ethnic differences and functional analysis of MET mutations in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19723643"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 11049,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with oral cavity cancer harboring MET N375S demonstrated progressive disease and overall survival of five weeks when treated with Xalkori (crizotinib) (PMID: 28514312).",
            "molecularProfile": {
                "id": 3165,
                "profileName": "MET N375S"
            },
            "therapy": {
                "id": 706,
                "therapyName": "Crizotinib",
                "synonyms": null
            },
            "indication": {
                "id": 8618,
                "name": "oral cavity cancer",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 9046,
                    "pubMedId": 28514312,
                    "title": "Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28514312"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7769,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, a patient with ovarian cancer harboring MET N375S demonstrated sensitivity to the combination treatment, Nexavar (sorafenib) and Avastin (bevacizumab), resulting in stable disease for greater than six months (PMID: 25363205).",
            "molecularProfile": {
                "id": 3165,
                "profileName": "MET N375S"
            },
            "therapy": {
                "id": 4517,
                "therapyName": "Bevacizumab + Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 4001,
                "name": "ovarian carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6478,
                    "pubMedId": 25363205,
                    "title": "Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25363205"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3165,
            "profileName": "MET N375S",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28958,
            "profileName": "ERBB2 pos KRAS amp MET N375S",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144816,
            "transcript": "NM_001127500",
            "gDna": "chr7:g.116700208A>G",
            "cDna": "c.1124A>G",
            "protein": "p.N375S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 144817,
            "transcript": "NM_000245",
            "gDna": "chr7:g.116700208A>G",
            "cDna": "c.1124A>G",
            "protein": "p.N375S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 144818,
            "transcript": "NM_001324401",
            "gDna": "chr7:g.116700208A>G",
            "cDna": "c.1124A>G",
            "protein": "p.N375S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}